Doug Taylor
Doug Taylor is an analyst at Canaccord Genuity, known for providing insights and recommendations on various stocks, particularly in the technology sector. He has a reputation for his analytical approach and has maintained a price target for Well Health Technologies despite the recent investigation affecting the company.
Not in the pool (under ¢1).
Recent news mentions
Doug Taylor is an analyst who described the changes at Calian as positive for the company.
Calian enters agreement with Plantro to shake up board, sell ‘non-core’ assets
Canada· 2025-11-12
Doug Taylor is an analyst who commented on the negative perception of MDA's situation.
MDA shares tumble on fears of satellite contract lossCanada· 2025-10-31
Doug Taylor raised his price target on MDA Space Ltd to C$45 from C$36.
Friday’s analyst upgrades and downgradesCanada· 2025-07-12
Doug Taylor is one of the founders of Projectworks, contributing to its development as a consultancy automation platform.
On the Up: ‘Emerging Company of the Year’ Projectworks raises US$10m, plans AI splash
New Zealand· 2025-06-03
Canaccord Genuity analyst Doug Taylor warns Lifespeak Inc. still faces significant growth and debt challenges.
Tuesday’s analyst upgrades and downgradesCanada· 2025-04-02
Doug Taylor maintained his $8.50 target for Well Health Technologies Corp.
Well Health shares tumble after company discloses investigation into U.S. subsidiaryCanada· 2025-03-31